Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy

Radioligand Therapy ◽

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy

Theranostics ◽

10.7150/thno.44556 ◽

2020 ◽

Vol 10 (17) ◽

pp. 7645-7655

Author(s):

Katharina Kessel ◽

Robert Seifert ◽

Matthias Weckesser ◽

Wolfgang Roll ◽

Verena Humberg ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular Analysis ◽

Radioligand Therapy ◽

Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-1549 ◽

2015 ◽

Vol 21 (14) ◽

pp. 3170-3177 ◽

Cited By ~ 36

Author(s):

Xu S. Xu ◽

Charles J. Ryan ◽

Kim Stuyckens ◽

Matthew R. Smith ◽

Fred Saad ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Abiraterone Acetate ◽

772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

European Urology Supplements ◽

10.1016/s1569-9056(16)60774-1 ◽

2016 ◽

Vol 15 (3) ◽

pp. e772-e772a

Author(s):

C. Van Praet ◽

S. Rottey ◽

F. Van Hende ◽

G. Pelgrims ◽

W. Demey ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Abiraterone Acetate ◽

177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

Journal of Nuclear Medicine ◽

10.2967/jnumed.118.223149 ◽

2019 ◽

Vol 60 (11) ◽

pp. 1579-1586 ◽

Cited By ~ 7

Author(s):

Jingjing Zhang ◽

Harshad R. Kulkarni ◽

Aviral Singh ◽

Christiane Schuchardt ◽

Karin Niepsch ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Radioligand Therapy ◽

Castration Resistant ◽

Functioning Kidney

MP57-10 RELATIONSHIP BETWEEN QUALITY OF LIFE AND OVERALL SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN ALSYMPCA: ANALYSIS BY PRIOR DOCETAXEL SUBGROUP

The Journal of Urology ◽

10.1016/j.juro.2017.02.1784 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Neal D. Shore ◽

Sten Nilsson ◽

Oliver Sartor ◽

Nicholas J. Vogelzang ◽

Robert E. Coleman ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Clinical experience with PSMA-Actinium-225 radioligand therapy in end-stage metastatic castration-resistant prostate cancer patients

European Urology Supplements ◽

10.1016/s1569-9056(18)31443-x ◽

2018 ◽

Vol 17 (2) ◽

pp. e875-e876 ◽

Cited By ~ 1

Author(s):

M. Van Der Doelen ◽

N. Mehra ◽

I. Van Oort ◽

M. Janssen ◽

U. Haberkorn ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Clinical Experience ◽

Radioligand Therapy ◽

Castration Resistant ◽

End Stage

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

Journal of Nuclear Medicine ◽

10.2967/jnumed.119.229229 ◽

2019 ◽

Vol 61 (1) ◽

pp. 62-69 ◽

Cited By ~ 26

Author(s):

Mike Sathekge ◽

Frank Bruchertseifer ◽

Mariza Vorster ◽

Ismaheel O. Lawal ◽

Otto Knoesen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Disease Free Survival ◽

Radioligand Therapy ◽

Free Survival ◽

Castration Resistant ◽

Disease Free

Clinical Variables Associated With Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Sipuleucel-T Immunotherapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.12.004 ◽

2018 ◽

Vol 16 (3) ◽

pp. 184-190.e2 ◽

Cited By ~ 5

Author(s):

Xiao X. Wei ◽

Jaselle Perry ◽

Emily Chang ◽

Li Zhang ◽

Robert A. Hiatt ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Clinical Variables ◽

Association of haptoglobin genetic polymorphism with overall survival in advanced castration-resistant prostate cancer patients with personalized peptide vaccination

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-1-s1-p56 ◽

2013 ◽

Vol 1 (S1) ◽

Author(s):

Nobukazu Komatsu ◽

Xiaoliang Pang ◽

Hiromitsu Araki ◽

Yoshiro Koda ◽

Kimiko Soejima ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Genetic Polymorphism ◽

Cancer Patients ◽

Peptide Vaccination ◽

Abstract 550: Cell-free DNA alterations in theAR/enhancer locus measured before AR signaling inhibition portend poor overall survival in metastatic castration resistant prostate cancer patients

10.1158/1538-7445.am2021-550 ◽

2021 ◽

Author(s):

Pradeep Singh Chauhan ◽

Steven H. Hartman ◽

Ha X. Dang ◽

Jace Webster ◽

Haley Ellis ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Poor Overall Survival ◽

Cell Free Dna ◽

Castration Resistant ◽

Free Dna ◽

Dna Alterations